AI assistant
Sending…
RESMED INC — Director's Dealing 2012
May 1, 2012
30071_dirs_2012-05-01_1909059d-e797-47f2-9c45-ead80cafa3a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-04-27
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-04-27 | ResMed Common Stock | M | 20000 | $23.095 | Acquired | 148410.086 | Direct |
| 2012-04-27 | ResMed Common Stock | S | 20000 | $34.00 | Disposed | 128410.086 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-04-27 | ResMed Common Stock Options | $23.095 | M | 20000 | Disposed | 2013-11-10 | ResMed Common Stock (20000) | Direct |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/4 annually until fully vested.
F2: Trade executed pursuant to a 10b5-1 trading plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29